Both the U.S. FDA and EU's MDR expect documented risk-based IQ, OQ, an PQs of medical packaging lines under U.S. FDA cGMP, EU MRD, ICH Q7 and Q9 and ISO 14971
Fax: +1-650-362-2367
Review a company's Installation and Qualification / Process Verification and Validation system for device and pharmaceutical packaging systems, methods, equipment, control of and testing for best practices as well as major cGMP deficiencies.
One major failing is lack of sufficient or targeted risk-based V&V planning and associated documentation. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 and ICH Q9 for hazard analysis and product risk management. Develop the Qualification Plan, including the requirements for equipment / process DQs, IQs, OQs, and PQs, or their equivalents. The field-tested examples address the key ares of packaging process and equipment, software VT&V, assuring key FDA requirements are not overlooked. The QMS and 21 CFR Part 11 and cybersecurity issues as needed are explained.
Why Should You Attend:Inspections of company packaging lines and their validation / qualification show major cGMP deficiencies. List as the instructor shares his expereince as a manufacturing engineer who set up new production and packaging lines, and as a QAE and QA Director and Consultant who inspected them for CGMP compliiance. Acceptable approaches and common mistakes. What is risk-based process V&V planning / execution. The "must have" elements from the CGMPs, ICH Q&, as well as how ISO 14971( and ICH Q9) for hazard analysis and product / process risk management fit in. Integration of the packaging line's equipment and process validation essentials into a company's overall quality management system.
Areas Covered in the Webinar:Participants will learn how an effective packaging installation and qualification is planned, executed, and documented. Also how it is effectively based n the critical requirement of a risk-based approach to compliance and personnel and product safety.
This webinar will provide valuable assistance to all regulated companies that need to review and modify their packagine lines, their installation or modification, and their qualification and proper execution / documentation. Geared to all FDA- regulated industries (and EU and Asia) The employees who will benefit include:
Principal, J E Lincoln and Associates
John E. Lincoln, is Principal of J. E. Lincoln and Associates LLC, a consulting company with over 42 years experience in U.S. FDA-regulated industries, 27 of which are as an independent consultant. John has worked with global companies to resolve regulatory issues, lead validations (hardware and software) and implement QMS/RA systems. He has published numerous articles in peer reviewed journals, 5 chapters in the RAPS textbook on Validation, conducted workshops and webinars worldwide. John is a graduate of UCLA.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email customercare@fdatrainingalert.com call +1-888-771-6965 (Toll Free).
This product hasn't received any reviews yet. Be the first to review this product! Write review